24 results
8-K
EX-2.1
VYNT
Vyant Bio, Inc.
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
Accounts Receivable
Section 3.23
Bank Accounts, Powers of Attorney
Section 3.24
Title to Personal Properties
Section 3.25
Anti-Corruption Laws
Section 3.26 … .
“Anti-Corruption Laws” shall mean the United States Foreign Corrupt Practices Act of 1977, as amended, and any other similar Laws concerning
425
EX-2.1
VYNT
Vyant Bio, Inc.
21 Sep 18
Business combination disclosure
4:06pm
; Regulatory Compliance
Section 3.22 Anti-Corruption Laws
Section 3.23 Fairness Opinion
Section 3.24 Insurance
Section 3.25 Books and Records
Section 3.26 … Compliance
Section 4.23 Anti-Corruption Laws
Section 4.24 Insurance
Section 4.25 Books and Records
Section 4.26 Grants and Subsidies
Section 4.27 No Other
8-K
EX-2.1
VYNT
Vyant Bio, Inc.
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
; Regulatory Compliance
Section 3.22 Anti-Corruption Laws
Section 3.23 Fairness Opinion
Section 3.24 Insurance
Section 3.25 Books and Records
Section 3.26 … Compliance
Section 4.23 Anti-Corruption Laws
Section 4.24 Insurance
Section 4.25 Books and Records
Section 4.26 Grants and Subsidies
Section 4.27 No Other
S-4
VYNT
Vyant Bio, Inc.
16 Oct 20
Registration of securities issued in business combination transactions
11:38am
, and other anti-corruption laws, as well as export control laws, import and customs laws, trade and economic sanctions laws and other laws governing our … operations.
Our operations are subject to anti-corruption laws, including the FCPA, the U.S. domestic bribery statute contained in 18 §201, the U.S
424B3
VYNT
Vyant Bio, Inc.
12 Feb 21
Prospectus supplement
9:43pm
to the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, and other anti-corruption laws, as well as export control laws, import … and customs laws, trade and economic sanctions laws and other laws governing our operations.
Our operations are subject to anti-corruption laws, including
S-4/A
9qne its8iz
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
8-K
EX-2.1
lwf5brwyt
19 Jul 19
Cancer Genetics, Inc. Announces Strategic Transactions
5:30pm
425
EX-2.1
sy8u4dwwi uuv
24 Aug 20
Business combination disclosure
8:41am
8-K
EX-2.1
k5yzc7 5kpj07z3
24 Aug 20
Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
8:42am